nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—colon cancer	0.639	1	CbGaD
Mefenamic acid—CYP2C9—Capecitabine—colon cancer	0.0365	0.409	CbGbCtD
Mefenamic acid—CYP2C8—Fluorouracil—colon cancer	0.0311	0.348	CbGbCtD
Mefenamic acid—CYP2C9—Fluorouracil—colon cancer	0.0217	0.243	CbGbCtD
Mefenamic acid—AKR1C3—Vinblastine—Vincristine—colon cancer	0.00546	1	CbGdCrCtD
Mefenamic acid—AKR1C2—liver—colon cancer	0.00434	0.113	CbGeAlD
Mefenamic acid—AKR1C2—lymph node—colon cancer	0.00333	0.0869	CbGeAlD
Mefenamic acid—AKR1C3—smooth muscle tissue—colon cancer	0.0023	0.0602	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—TP53—colon cancer	0.00208	0.212	CrCbGaD
Mefenamic acid—PTGS1—endothelium—colon cancer	0.00188	0.0492	CbGeAlD
Mefenamic acid—PTGS2—endothelium—colon cancer	0.0018	0.047	CbGeAlD
Mefenamic acid—PTGS1—blood vessel—colon cancer	0.00174	0.0454	CbGeAlD
Mefenamic acid—AKR1C3—bone marrow—colon cancer	0.00168	0.0438	CbGeAlD
Mefenamic acid—PTGS2—blood vessel—colon cancer	0.00166	0.0434	CbGeAlD
Mefenamic acid—AKR1C3—vagina—colon cancer	0.00161	0.0419	CbGeAlD
Mefenamic acid—PTGS2—gall bladder—colon cancer	0.00156	0.0408	CbGeAlD
Mefenamic acid—AKR1C3—liver—colon cancer	0.00135	0.0354	CbGeAlD
Mefenamic acid—Floctafenine—PTGS2—colon cancer	0.00107	0.109	CrCbGaD
Mefenamic acid—AKR1C3—lymph node—colon cancer	0.00104	0.0271	CbGeAlD
Mefenamic acid—PTGS2—embryo—colon cancer	0.00099	0.0259	CbGeAlD
Mefenamic acid—CYP2C8—renal system—colon cancer	0.000967	0.0253	CbGeAlD
Mefenamic acid—PTGS1—epithelium—colon cancer	0.000845	0.0221	CbGeAlD
Mefenamic acid—PTGS1—smooth muscle tissue—colon cancer	0.000815	0.0213	CbGeAlD
Mefenamic acid—PTGS2—epithelium—colon cancer	0.000808	0.0211	CbGeAlD
Mefenamic acid—PTGS1—renal system—colon cancer	0.000784	0.0205	CbGeAlD
Mefenamic acid—PTGS2—smooth muscle tissue—colon cancer	0.000779	0.0203	CbGeAlD
Mefenamic acid—PTGS2—renal system—colon cancer	0.000749	0.0196	CbGeAlD
Mefenamic acid—CYP2C9—digestive system—colon cancer	0.000704	0.0184	CbGeAlD
Mefenamic acid—CYP2C8—vagina—colon cancer	0.0007	0.0183	CbGeAlD
Mefenamic acid—Tiaprofenic acid—PTGS2—colon cancer	0.000689	0.0702	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS2—colon cancer	0.000689	0.0702	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—colon cancer	0.000655	0.0668	CrCbGaD
Mefenamic acid—PTGS1—digestive system—colon cancer	0.000643	0.0168	CbGeAlD
Mefenamic acid—PTGS2—lymphoid tissue—colon cancer	0.000622	0.0163	CbGeAlD
Mefenamic acid—PTGS2—digestive system—colon cancer	0.000615	0.0161	CbGeAlD
Mefenamic acid—Niflumic Acid—PTGS2—colon cancer	0.000614	0.0626	CrCbGaD
Mefenamic acid—Aplastic anaemia—Methotrexate—colon cancer	0.000592	0.00339	CcSEcCtD
Mefenamic acid—CYP2C8—liver—colon cancer	0.000591	0.0154	CbGeAlD
Mefenamic acid—Alopecia—Vincristine—colon cancer	0.000577	0.0033	CcSEcCtD
Mefenamic acid—Coma—Methotrexate—colon cancer	0.000576	0.0033	CcSEcCtD
Mefenamic acid—Mental disorder—Vincristine—colon cancer	0.000572	0.00327	CcSEcCtD
Mefenamic acid—Ecchymosis—Methotrexate—colon cancer	0.00057	0.00326	CcSEcCtD
Mefenamic acid—Urine output increased—Methotrexate—colon cancer	0.00057	0.00326	CcSEcCtD
Mefenamic acid—Bladder pain—Methotrexate—colon cancer	0.00057	0.00326	CcSEcCtD
Mefenamic acid—PTGS1—vagina—colon cancer	0.000568	0.0148	CbGeAlD
Mefenamic acid—Arrhythmia—Irinotecan—colon cancer	0.000568	0.00325	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Capecitabine—colon cancer	0.000568	0.00325	CcSEcCtD
Mefenamic acid—PTGS2—bone marrow—colon cancer	0.000567	0.0148	CbGeAlD
Mefenamic acid—Alopecia—Irinotecan—colon cancer	0.000561	0.00322	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000554	0.00317	CcSEcCtD
Mefenamic acid—Sepsis—Methotrexate—colon cancer	0.000547	0.00313	CcSEcCtD
Mefenamic acid—Flatulence—Irinotecan—colon cancer	0.000545	0.00312	CcSEcCtD
Mefenamic acid—Salsalate—PTGS2—colon cancer	0.000544	0.0555	CrCbGaD
Mefenamic acid—Gastritis—Capecitabine—colon cancer	0.000544	0.00312	CcSEcCtD
Mefenamic acid—Arrhythmia—Fluorouracil—colon cancer	0.000544	0.00311	CcSEcCtD
Mefenamic acid—PTGS2—vagina—colon cancer	0.000543	0.0142	CbGeAlD
Mefenamic acid—Alopecia—Fluorouracil—colon cancer	0.000538	0.00308	CcSEcCtD
Mefenamic acid—Meclofenamic acid—PTGS2—colon cancer	0.000536	0.0547	CrCbGaD
Mefenamic acid—Lymphadenopathy—Methotrexate—colon cancer	0.000536	0.00307	CcSEcCtD
Mefenamic acid—Asthma—Capecitabine—colon cancer	0.000531	0.00304	CcSEcCtD
Mefenamic acid—Anaemia—Vincristine—colon cancer	0.000525	0.00301	CcSEcCtD
Mefenamic acid—CYP2C9—liver—colon cancer	0.000525	0.0137	CbGeAlD
Mefenamic acid—Photosensitivity—Methotrexate—colon cancer	0.000521	0.00298	CcSEcCtD
Mefenamic acid—Polyuria—Methotrexate—colon cancer	0.000521	0.00298	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Irinotecan—colon cancer	0.000513	0.00294	CcSEcCtD
Mefenamic acid—Anaemia—Irinotecan—colon cancer	0.000511	0.00293	CcSEcCtD
Mefenamic acid—Vertigo—Vincristine—colon cancer	0.00051	0.00292	CcSEcCtD
Mefenamic acid—Hepatic failure—Methotrexate—colon cancer	0.000509	0.00292	CcSEcCtD
Mefenamic acid—Leukopenia—Vincristine—colon cancer	0.000508	0.00291	CcSEcCtD
Mefenamic acid—Pancytopenia—Capecitabine—colon cancer	0.000505	0.00289	CcSEcCtD
Mefenamic acid—Vision blurred—Fluorouracil—colon cancer	0.000499	0.00286	CcSEcCtD
Mefenamic acid—Malaise—Irinotecan—colon cancer	0.000499	0.00286	CcSEcCtD
Mefenamic acid—Vertigo—Irinotecan—colon cancer	0.000497	0.00285	CcSEcCtD
Mefenamic acid—Dysuria—Capecitabine—colon cancer	0.000497	0.00285	CcSEcCtD
Mefenamic acid—Syncope—Irinotecan—colon cancer	0.000496	0.00284	CcSEcCtD
Mefenamic acid—Leukopenia—Irinotecan—colon cancer	0.000495	0.00284	CcSEcCtD
Mefenamic acid—Convulsion—Vincristine—colon cancer	0.000492	0.00282	CcSEcCtD
Mefenamic acid—Hypertension—Vincristine—colon cancer	0.00049	0.00281	CcSEcCtD
Mefenamic acid—Anaemia—Fluorouracil—colon cancer	0.00049	0.0028	CcSEcCtD
Mefenamic acid—Loss of consciousness—Irinotecan—colon cancer	0.000486	0.00278	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Methotrexate—colon cancer	0.000485	0.00278	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Capecitabine—colon cancer	0.000485	0.00278	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Capecitabine—colon cancer	0.000479	0.00275	CcSEcCtD
Mefenamic acid—Hypertension—Irinotecan—colon cancer	0.000478	0.00274	CcSEcCtD
Mefenamic acid—Pneumonia—Capecitabine—colon cancer	0.000476	0.00273	CcSEcCtD
Mefenamic acid—Leukopenia—Fluorouracil—colon cancer	0.000474	0.00272	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Methotrexate—colon cancer	0.000473	0.00271	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00047	0.00269	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Capecitabine—colon cancer	0.000467	0.00267	CcSEcCtD
Mefenamic acid—Renal failure—Capecitabine—colon cancer	0.000466	0.00267	CcSEcCtD
Mefenamic acid—Discomfort—Irinotecan—colon cancer	0.000465	0.00266	CcSEcCtD
Mefenamic acid—Myocardial infarction—Capecitabine—colon cancer	0.000464	0.00266	CcSEcCtD
Mefenamic acid—Oedema—Vincristine—colon cancer	0.000464	0.00265	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Vincristine—colon cancer	0.000464	0.00265	CcSEcCtD
Mefenamic acid—Stomatitis—Capecitabine—colon cancer	0.000462	0.00264	CcSEcCtD
Mefenamic acid—Jaundice—Capecitabine—colon cancer	0.000462	0.00264	CcSEcCtD
Mefenamic acid—Infection—Vincristine—colon cancer	0.00046	0.00264	CcSEcCtD
Mefenamic acid—Conjunctivitis—Capecitabine—colon cancer	0.00046	0.00264	CcSEcCtD
Mefenamic acid—Convulsion—Fluorouracil—colon cancer	0.000459	0.00263	CcSEcCtD
Mefenamic acid—PTGS2—liver—colon cancer	0.000458	0.012	CbGeAlD
Mefenamic acid—Confusional state—Irinotecan—colon cancer	0.000455	0.00261	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Vincristine—colon cancer	0.000454	0.0026	CcSEcCtD
Mefenamic acid—Haematuria—Capecitabine—colon cancer	0.000452	0.00259	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Irinotecan—colon cancer	0.000451	0.00259	CcSEcCtD
Mefenamic acid—Oedema—Irinotecan—colon cancer	0.000451	0.00259	CcSEcCtD
Mefenamic acid—Fenoprofen—PTGS2—colon cancer	0.00045	0.0459	CrCbGaD
Mefenamic acid—Infection—Irinotecan—colon cancer	0.000448	0.00257	CcSEcCtD
Mefenamic acid—Discomfort—Fluorouracil—colon cancer	0.000446	0.00255	CcSEcCtD
Mefenamic acid—Shock—Irinotecan—colon cancer	0.000444	0.00254	CcSEcCtD
Mefenamic acid—Agranulocytosis—Capecitabine—colon cancer	0.000442	0.00253	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Irinotecan—colon cancer	0.000442	0.00253	CcSEcCtD
Mefenamic acid—Anorexia—Vincristine—colon cancer	0.000442	0.00253	CcSEcCtD
Mefenamic acid—Confusional state—Fluorouracil—colon cancer	0.000436	0.0025	CcSEcCtD
Mefenamic acid—Hypotension—Vincristine—colon cancer	0.000433	0.00248	CcSEcCtD
Mefenamic acid—Oedema—Fluorouracil—colon cancer	0.000432	0.00248	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Fluorouracil—colon cancer	0.000432	0.00248	CcSEcCtD
Mefenamic acid—Anorexia—Irinotecan—colon cancer	0.00043	0.00246	CcSEcCtD
Mefenamic acid—Infection—Fluorouracil—colon cancer	0.00043	0.00246	CcSEcCtD
Mefenamic acid—Haemoglobin—Capecitabine—colon cancer	0.000427	0.00245	CcSEcCtD
Mefenamic acid—Hepatitis—Capecitabine—colon cancer	0.000425	0.00244	CcSEcCtD
Mefenamic acid—Haemorrhage—Capecitabine—colon cancer	0.000425	0.00244	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Fluorouracil—colon cancer	0.000423	0.00242	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Methotrexate—colon cancer	0.000422	0.00242	CcSEcCtD
Mefenamic acid—Tachycardia—Fluorouracil—colon cancer	0.000422	0.00242	CcSEcCtD
Mefenamic acid—Hypotension—Irinotecan—colon cancer	0.000422	0.00242	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Capecitabine—colon cancer	0.00042	0.00241	CcSEcCtD
Mefenamic acid—Insomnia—Vincristine—colon cancer	0.000419	0.0024	CcSEcCtD
Mefenamic acid—Urethral disorder—Capecitabine—colon cancer	0.000417	0.00239	CcSEcCtD
Mefenamic acid—Paraesthesia—Vincristine—colon cancer	0.000416	0.00238	CcSEcCtD
Mefenamic acid—Anorexia—Fluorouracil—colon cancer	0.000412	0.00236	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000412	0.00236	CcSEcCtD
Mefenamic acid—Insomnia—Irinotecan—colon cancer	0.000408	0.00234	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS2—colon cancer	0.000407	0.0414	CrCbGaD
Mefenamic acid—Paraesthesia—Irinotecan—colon cancer	0.000405	0.00232	CcSEcCtD
Mefenamic acid—Hypotension—Fluorouracil—colon cancer	0.000404	0.00231	CcSEcCtD
Mefenamic acid—Decreased appetite—Vincristine—colon cancer	0.000403	0.00231	CcSEcCtD
Mefenamic acid—Dyspnoea—Irinotecan—colon cancer	0.000402	0.00231	CcSEcCtD
Mefenamic acid—Erythema multiforme—Capecitabine—colon cancer	0.000402	0.0023	CcSEcCtD
Mefenamic acid—Somnolence—Irinotecan—colon cancer	0.000401	0.0023	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Vincristine—colon cancer	0.0004	0.00229	CcSEcCtD
Mefenamic acid—Dyspepsia—Irinotecan—colon cancer	0.000397	0.00228	CcSEcCtD
Mefenamic acid—Tinnitus—Capecitabine—colon cancer	0.000396	0.00227	CcSEcCtD
Mefenamic acid—Constipation—Vincristine—colon cancer	0.000396	0.00227	CcSEcCtD
Mefenamic acid—Asthma—Methotrexate—colon cancer	0.000395	0.00227	CcSEcCtD
Mefenamic acid—Decreased appetite—Irinotecan—colon cancer	0.000392	0.00225	CcSEcCtD
Mefenamic acid—Eosinophilia—Methotrexate—colon cancer	0.000392	0.00224	CcSEcCtD
Mefenamic acid—Insomnia—Fluorouracil—colon cancer	0.000391	0.00224	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.00039	0.00223	CcSEcCtD
Mefenamic acid—Paraesthesia—Fluorouracil—colon cancer	0.000388	0.00222	CcSEcCtD
Mefenamic acid—Pancreatitis—Methotrexate—colon cancer	0.000388	0.00222	CcSEcCtD
Mefenamic acid—Constipation—Irinotecan—colon cancer	0.000386	0.00221	CcSEcCtD
Mefenamic acid—Dyspnoea—Fluorouracil—colon cancer	0.000385	0.00221	CcSEcCtD
Mefenamic acid—Somnolence—Fluorouracil—colon cancer	0.000384	0.0022	CcSEcCtD
Mefenamic acid—Dyspepsia—Fluorouracil—colon cancer	0.000381	0.00218	CcSEcCtD
Mefenamic acid—Arrhythmia—Capecitabine—colon cancer	0.00038	0.00218	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Vincristine—colon cancer	0.000379	0.00217	CcSEcCtD
Mefenamic acid—Decreased appetite—Fluorouracil—colon cancer	0.000376	0.00215	CcSEcCtD
Mefenamic acid—Alopecia—Capecitabine—colon cancer	0.000376	0.00215	CcSEcCtD
Mefenamic acid—Pancytopenia—Methotrexate—colon cancer	0.000376	0.00215	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—LGR5—colon cancer	0.000373	0.00859	CbGpPWpGaD
Mefenamic acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000373	0.00214	CcSEcCtD
Mefenamic acid—Mental disorder—Capecitabine—colon cancer	0.000373	0.00213	CcSEcCtD
Mefenamic acid—Feeling abnormal—Irinotecan—colon cancer	0.000372	0.00213	CcSEcCtD
Mefenamic acid—Dysuria—Methotrexate—colon cancer	0.00037	0.00212	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Irinotecan—colon cancer	0.000369	0.00211	CcSEcCtD
Mefenamic acid—PTGS1—lymph node—colon cancer	0.000367	0.0096	CbGeAlD
Mefenamic acid—Abdominal pain—Vincristine—colon cancer	0.000366	0.0021	CcSEcCtD
Mefenamic acid—Body temperature increased—Vincristine—colon cancer	0.000366	0.0021	CcSEcCtD
Mefenamic acid—Flatulence—Capecitabine—colon cancer	0.000365	0.00209	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Methotrexate—colon cancer	0.000361	0.00207	CcSEcCtD
Mefenamic acid—Abdominal pain—Irinotecan—colon cancer	0.000357	0.00204	CcSEcCtD
Mefenamic acid—Body temperature increased—Irinotecan—colon cancer	0.000357	0.00204	CcSEcCtD
Mefenamic acid—Feeling abnormal—Fluorouracil—colon cancer	0.000356	0.00204	CcSEcCtD
Mefenamic acid—Pneumonia—Methotrexate—colon cancer	0.000355	0.00203	CcSEcCtD
Mefenamic acid—Drowsiness—Methotrexate—colon cancer	0.000353	0.00202	CcSEcCtD
Mefenamic acid—PTGS2—lymph node—colon cancer	0.000351	0.00918	CbGeAlD
Mefenamic acid—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00035	0.002	CcSEcCtD
Mefenamic acid—Vision blurred—Capecitabine—colon cancer	0.000349	0.002	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—CA7—colon cancer	0.000347	0.00799	CbGpPWpGaD
Mefenamic acid—Tremor—Capecitabine—colon cancer	0.000347	0.00199	CcSEcCtD
Mefenamic acid—Renal failure—Methotrexate—colon cancer	0.000347	0.00199	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ABCB1—colon cancer	0.000346	0.0352	CrCbGaD
Mefenamic acid—Stomatitis—Methotrexate—colon cancer	0.000344	0.00197	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Capecitabine—colon cancer	0.000343	0.00197	CcSEcCtD
Mefenamic acid—Urticaria—Fluorouracil—colon cancer	0.000343	0.00197	CcSEcCtD
Mefenamic acid—Conjunctivitis—Methotrexate—colon cancer	0.000343	0.00196	CcSEcCtD
Mefenamic acid—Anaemia—Capecitabine—colon cancer	0.000342	0.00196	CcSEcCtD
Mefenamic acid—Body temperature increased—Fluorouracil—colon cancer	0.000342	0.00196	CcSEcCtD
Mefenamic acid—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	0.000341	0.00785	CbGpPWpGaD
Mefenamic acid—Haematuria—Methotrexate—colon cancer	0.000336	0.00193	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—colon cancer	0.000335	0.0341	CrCbGaD
Mefenamic acid—Malaise—Capecitabine—colon cancer	0.000334	0.00191	CcSEcCtD
Mefenamic acid—Vertigo—Capecitabine—colon cancer	0.000333	0.00191	CcSEcCtD
Mefenamic acid—Asthenia—Vincristine—colon cancer	0.000333	0.0019	CcSEcCtD
Mefenamic acid—Syncope—Capecitabine—colon cancer	0.000332	0.0019	CcSEcCtD
Mefenamic acid—Leukopenia—Capecitabine—colon cancer	0.000331	0.0019	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—colon cancer	0.000329	0.00188	CcSEcCtD
Mefenamic acid—Palpitations—Capecitabine—colon cancer	0.000327	0.00187	CcSEcCtD
Mefenamic acid—Loss of consciousness—Capecitabine—colon cancer	0.000325	0.00186	CcSEcCtD
Mefenamic acid—Asthenia—Irinotecan—colon cancer	0.000324	0.00186	CcSEcCtD
Mefenamic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.000324	0.00745	CbGpPWpGaD
Mefenamic acid—Hypertension—Capecitabine—colon cancer	0.00032	0.00183	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—colon cancer	0.000318	0.00182	CcSEcCtD
Mefenamic acid—Diarrhoea—Vincristine—colon cancer	0.000317	0.00182	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—colon cancer	0.000317	0.00181	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—colon cancer	0.000317	0.00181	CcSEcCtD
Mefenamic acid—Anxiety—Capecitabine—colon cancer	0.000314	0.0018	CcSEcCtD
Mefenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000313	0.00721	CbGpPWpGaD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000313	0.00179	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—ODC1—colon cancer	0.000313	0.0072	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CHST5—colon cancer	0.000313	0.0072	CbGpPWpGaD
Mefenamic acid—Urinary tract disorder—Methotrexate—colon cancer	0.000313	0.00179	CcSEcCtD
Mefenamic acid—Discomfort—Capecitabine—colon cancer	0.000311	0.00178	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—colon cancer	0.00031	0.00178	CcSEcCtD
Mefenamic acid—Diarrhoea—Irinotecan—colon cancer	0.000309	0.00177	CcSEcCtD
Mefenamic acid—Dry mouth—Capecitabine—colon cancer	0.000308	0.00177	CcSEcCtD
Mefenamic acid—Dizziness—Vincristine—colon cancer	0.000307	0.00176	CcSEcCtD
Mefenamic acid—Pruritus—Fluorouracil—colon cancer	0.000306	0.00175	CcSEcCtD
Mefenamic acid—Confusional state—Capecitabine—colon cancer	0.000305	0.00174	CcSEcCtD
Mefenamic acid—Oedema—Capecitabine—colon cancer	0.000302	0.00173	CcSEcCtD
Mefenamic acid—Infection—Capecitabine—colon cancer	0.0003	0.00172	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—colon cancer	0.0003	0.0306	CrCbGaD
Mefenamic acid—Erythema multiforme—Methotrexate—colon cancer	0.000299	0.00171	CcSEcCtD
Mefenamic acid—Dizziness—Irinotecan—colon cancer	0.000299	0.00171	CcSEcCtD
Mefenamic acid—Shock—Capecitabine—colon cancer	0.000297	0.0017	CcSEcCtD
Mefenamic acid—Diarrhoea—Fluorouracil—colon cancer	0.000296	0.00169	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Capecitabine—colon cancer	0.000296	0.00169	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—colon cancer	0.000295	0.00169	CcSEcCtD
Mefenamic acid—Tachycardia—Capecitabine—colon cancer	0.000295	0.00169	CcSEcCtD
Mefenamic acid—Vomiting—Vincristine—colon cancer	0.000295	0.00169	CcSEcCtD
Mefenamic acid—Skin disorder—Capecitabine—colon cancer	0.000293	0.00168	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—colon cancer	0.000293	0.0299	CrCbGaD
Mefenamic acid—Rash—Vincristine—colon cancer	0.000292	0.00167	CcSEcCtD
Mefenamic acid—Dermatitis—Vincristine—colon cancer	0.000292	0.00167	CcSEcCtD
Mefenamic acid—Headache—Vincristine—colon cancer	0.00029	0.00166	CcSEcCtD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000288	0.00663	CbGpPWpGaD
Mefenamic acid—Anorexia—Capecitabine—colon cancer	0.000288	0.00165	CcSEcCtD
Mefenamic acid—Vomiting—Irinotecan—colon cancer	0.000287	0.00164	CcSEcCtD
Mefenamic acid—Dizziness—Fluorouracil—colon cancer	0.000286	0.00164	CcSEcCtD
Mefenamic acid—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000286	0.00657	CbGpPWpGaD
Mefenamic acid—Salicylic acid—ABCB1—colon cancer	0.000285	0.029	CrCbGaD
Mefenamic acid—Rash—Irinotecan—colon cancer	0.000285	0.00163	CcSEcCtD
Mefenamic acid—Dermatitis—Irinotecan—colon cancer	0.000284	0.00163	CcSEcCtD
Mefenamic acid—Headache—Irinotecan—colon cancer	0.000283	0.00162	CcSEcCtD
Mefenamic acid—Hypotension—Capecitabine—colon cancer	0.000282	0.00162	CcSEcCtD
Mefenamic acid—PTGS2—S1P1 pathway—VEGFA—colon cancer	0.000282	0.00649	CbGpPWpGaD
Mefenamic acid—Alopecia—Methotrexate—colon cancer	0.00028	0.0016	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—DLC1—colon cancer	0.000278	0.0064	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	0.000278	0.00639	CbGpPWpGaD
Mefenamic acid—Mental disorder—Methotrexate—colon cancer	0.000277	0.00159	CcSEcCtD
Mefenamic acid—Nausea—Vincristine—colon cancer	0.000275	0.00158	CcSEcCtD
Mefenamic acid—Vomiting—Fluorouracil—colon cancer	0.000275	0.00157	CcSEcCtD
Mefenamic acid—Insomnia—Capecitabine—colon cancer	0.000273	0.00157	CcSEcCtD
Mefenamic acid—Rash—Fluorouracil—colon cancer	0.000273	0.00156	CcSEcCtD
Mefenamic acid—Dermatitis—Fluorouracil—colon cancer	0.000272	0.00156	CcSEcCtD
Mefenamic acid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000272	0.00626	CbGpPWpGaD
Mefenamic acid—Paraesthesia—Capecitabine—colon cancer	0.000271	0.00155	CcSEcCtD
Mefenamic acid—Headache—Fluorouracil—colon cancer	0.000271	0.00155	CcSEcCtD
Mefenamic acid—Dyspnoea—Capecitabine—colon cancer	0.000269	0.00154	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—AXIN2—colon cancer	0.000268	0.00617	CbGpPWpGaD
Mefenamic acid—Nausea—Irinotecan—colon cancer	0.000268	0.00154	CcSEcCtD
Mefenamic acid—Dyspepsia—Capecitabine—colon cancer	0.000266	0.00152	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—colon cancer	0.000265	0.0271	CrCbGaD
Mefenamic acid—Decreased appetite—Capecitabine—colon cancer	0.000263	0.0015	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—LGR5—colon cancer	0.000262	0.00602	CbGpPWpGaD
Mefenamic acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000261	0.00149	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—colon cancer	0.00026	0.00149	CcSEcCtD
Mefenamic acid—Constipation—Capecitabine—colon cancer	0.000258	0.00148	CcSEcCtD
Mefenamic acid—Nausea—Fluorouracil—colon cancer	0.000257	0.00147	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—colon cancer	0.000256	0.00146	CcSEcCtD
Mefenamic acid—Diclofenac—ABCB1—colon cancer	0.000255	0.026	CrCbGaD
Mefenamic acid—Anaemia—Methotrexate—colon cancer	0.000255	0.00146	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—CHST5—colon cancer	0.000251	0.00578	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—LGR5—colon cancer	0.000251	0.00578	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Capecitabine—colon cancer	0.000249	0.00143	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—colon cancer	0.000249	0.00142	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—colon cancer	0.000248	0.00142	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Capecitabine—colon cancer	0.000247	0.00142	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—colon cancer	0.000247	0.00141	CcSEcCtD
Mefenamic acid—Urticaria—Capecitabine—colon cancer	0.00024	0.00137	CcSEcCtD
Mefenamic acid—Body temperature increased—Capecitabine—colon cancer	0.000239	0.00137	CcSEcCtD
Mefenamic acid—Abdominal pain—Capecitabine—colon cancer	0.000239	0.00137	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—colon cancer	0.000239	0.00137	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000233	0.00133	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—colon cancer	0.000232	0.00133	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—colon cancer	0.000227	0.0013	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—colon cancer	0.000225	0.00129	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—colon cancer	0.000223	0.00128	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—colon cancer	0.00022	0.00126	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—colon cancer	0.000218	0.00125	CcSEcCtD
Mefenamic acid—Asthenia—Capecitabine—colon cancer	0.000217	0.00124	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—colon cancer	0.000214	0.00123	CcSEcCtD
Mefenamic acid—Pruritus—Capecitabine—colon cancer	0.000214	0.00122	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—CHST5—colon cancer	0.00021	0.00484	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ODC1—colon cancer	0.00021	0.00484	CbGpPWpGaD
Mefenamic acid—Hypotension—Methotrexate—colon cancer	0.00021	0.0012	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.00021	0.00483	CbGpPWpGaD
Mefenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	0.000208	0.00479	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Capecitabine—colon cancer	0.000207	0.00118	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—colon cancer	0.000203	0.00117	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—colon cancer	0.000202	0.00116	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—colon cancer	0.000201	0.00115	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—colon cancer	0.0002	0.00115	CcSEcCtD
Mefenamic acid—Dizziness—Capecitabine—colon cancer	0.0002	0.00114	CcSEcCtD
Mefenamic acid—Dyspepsia—Methotrexate—colon cancer	0.000198	0.00113	CcSEcCtD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000197	0.00453	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Methotrexate—colon cancer	0.000196	0.00112	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000194	0.00111	CcSEcCtD
Mefenamic acid—Vomiting—Capecitabine—colon cancer	0.000192	0.0011	CcSEcCtD
Mefenamic acid—Rash—Capecitabine—colon cancer	0.00019	0.00109	CcSEcCtD
Mefenamic acid—Dermatitis—Capecitabine—colon cancer	0.00019	0.00109	CcSEcCtD
Mefenamic acid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000189	0.00436	CbGpPWpGaD
Mefenamic acid—Headache—Capecitabine—colon cancer	0.000189	0.00108	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—AXIN2—colon cancer	0.000188	0.00432	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—DLC1—colon cancer	0.000187	0.00431	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Methotrexate—colon cancer	0.000185	0.00106	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—colon cancer	0.000184	0.00105	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—AXIN2—colon cancer	0.000181	0.00415	CbGpPWpGaD
Mefenamic acid—Nausea—Capecitabine—colon cancer	0.000179	0.00103	CcSEcCtD
Mefenamic acid—Urticaria—Methotrexate—colon cancer	0.000179	0.00102	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—colon cancer	0.000178	0.00102	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—colon cancer	0.000178	0.00102	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—LGR5—colon cancer	0.000176	0.00405	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000176	0.00405	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000166	0.00381	CbGpPWpGaD
Mefenamic acid—Asthenia—Methotrexate—colon cancer	0.000161	0.000924	CcSEcCtD
Mefenamic acid—Pruritus—Methotrexate—colon cancer	0.000159	0.000911	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000154	0.00355	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Methotrexate—colon cancer	0.000154	0.000881	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.000153	0.00353	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CA7—colon cancer	0.000151	0.00348	CbGpPWpGaD
Mefenamic acid—Dizziness—Methotrexate—colon cancer	0.000149	0.000852	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000147	0.00338	CbGpPWpGaD
Mefenamic acid—Vomiting—Methotrexate—colon cancer	0.000143	0.000819	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000143	0.00329	CbGpPWpGaD
Mefenamic acid—Rash—Methotrexate—colon cancer	0.000142	0.000812	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—colon cancer	0.000142	0.000811	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—colon cancer	0.000141	0.000807	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000139	0.0032	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000138	0.00318	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000137	0.00316	CbGpPWpGaD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	0.000134	0.00309	CbGpPWpGaD
Mefenamic acid—Nausea—Methotrexate—colon cancer	0.000134	0.000765	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	0.000132	0.00305	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000132	0.00305	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000131	0.00301	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000129	0.00297	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000128	0.00295	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AXIN2—colon cancer	0.000126	0.00291	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000125	0.00288	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CA7—colon cancer	0.00012	0.00276	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000118	0.00272	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000115	0.00265	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ABCB1—colon cancer	0.000113	0.00259	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—TYMS—colon cancer	0.000111	0.00254	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	0.000109	0.00252	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000103	0.00238	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000102	0.00234	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000101	0.00233	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000101	0.00231	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	9.86e-05	0.00227	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	9.78e-05	0.00225	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA7—colon cancer	9.77e-05	0.00225	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	9.54e-05	0.00219	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CHST5—colon cancer	9.16e-05	0.00211	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ODC1—colon cancer	9.16e-05	0.00211	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—EP300—colon cancer	9.07e-05	0.00209	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.69e-05	0.002	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LGR5—colon cancer	8.68e-05	0.002	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CHST5—colon cancer	8.68e-05	0.002	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.51e-05	0.00196	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	8.49e-05	0.00195	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.45e-05	0.00194	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ABCB1—colon cancer	8.26e-05	0.0019	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—TYMS—colon cancer	8.12e-05	0.00187	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA7—colon cancer	7.95e-05	0.00183	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—MYC—colon cancer	7.91e-05	0.00182	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PPARG—colon cancer	7.83e-05	0.0018	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—FGFR3—colon cancer	7.75e-05	0.00178	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CASP3—colon cancer	7.72e-05	0.00178	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CCND1—colon cancer	7.51e-05	0.00173	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	7.45e-05	0.00171	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	7.31e-05	0.00168	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ODC1—colon cancer	7.27e-05	0.00167	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CHST5—colon cancer	7.27e-05	0.00167	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—APC—colon cancer	7.11e-05	0.00164	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.83e-05	0.00157	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—BRAF—colon cancer	6.69e-05	0.00154	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.25e-05	0.00144	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AXIN2—colon cancer	6.24e-05	0.00144	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	6.21e-05	0.00143	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PTGS2—colon cancer	6.16e-05	0.00142	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MYC—colon cancer	6.02e-05	0.00139	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	6.01e-05	0.00138	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ODC1—colon cancer	5.92e-05	0.00136	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CHST5—colon cancer	5.92e-05	0.00136	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—EGFR—colon cancer	5.89e-05	0.00136	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PPARG—colon cancer	5.75e-05	0.00132	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.68e-05	0.00131	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ABCB1—colon cancer	5.56e-05	0.00128	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—TYMS—colon cancer	5.46e-05	0.00126	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—FGFR3—colon cancer	5.43e-05	0.00125	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTGS2—colon cancer	5.4e-05	0.00124	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	5.25e-05	0.00121	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—FGFR3—colon cancer	5.21e-05	0.0012	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—EP300—colon cancer	5.13e-05	0.00118	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	5.11e-05	0.00118	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	5.06e-05	0.00116	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APC—colon cancer	4.98e-05	0.00115	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—colon cancer	4.95e-05	0.00114	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	4.94e-05	0.00114	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CTNNB1—colon cancer	4.83e-05	0.00111	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CHST5—colon cancer	4.82e-05	0.00111	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ODC1—colon cancer	4.82e-05	0.00111	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APC—colon cancer	4.79e-05	0.0011	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1A—colon cancer	4.72e-05	0.00109	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.7e-05	0.00108	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—BRAF—colon cancer	4.68e-05	0.00108	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.57e-05	0.00105	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—colon cancer	4.52e-05	0.00104	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—BRAF—colon cancer	4.5e-05	0.00104	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EP300—colon cancer	4.49e-05	0.00103	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.45e-05	0.00102	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SRC—colon cancer	4.37e-05	0.001	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.2e-05	0.000967	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NRAS—colon cancer	4.2e-05	0.000967	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.1e-05	0.000943	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.09e-05	0.000941	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.01e-05	0.000922	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—colon cancer	3.91e-05	0.000901	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—colon cancer	3.9e-05	0.000898	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—colon cancer	3.87e-05	0.00089	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—colon cancer	3.83e-05	0.000881	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—colon cancer	3.79e-05	0.000872	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.79e-05	0.000871	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.78e-05	0.00087	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—EP300—colon cancer	3.76e-05	0.000865	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FGFR3—colon cancer	3.65e-05	0.00084	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—colon cancer	3.63e-05	0.000836	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KRAS—colon cancer	3.62e-05	0.000832	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP3—colon cancer	3.51e-05	0.000808	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.48e-05	0.0008	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—colon cancer	3.42e-05	0.000786	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CTNNB1—colon cancer	3.38e-05	0.000779	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.37e-05	0.000774	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APC—colon cancer	3.35e-05	0.000771	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—colon cancer	3.32e-05	0.000764	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1A—colon cancer	3.31e-05	0.000761	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CTNNB1—colon cancer	3.25e-05	0.000748	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1A—colon cancer	3.18e-05	0.000731	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—BRAF—colon cancer	3.15e-05	0.000725	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EP300—colon cancer	3.15e-05	0.000724	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—colon cancer	3.1e-05	0.000713	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HRAS—colon cancer	3.07e-05	0.000707	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SRC—colon cancer	3.06e-05	0.000704	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—colon cancer	3.04e-05	0.0007	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EP300—colon cancer	3.02e-05	0.000695	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3e-05	0.000691	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—colon cancer	2.98e-05	0.000685	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.97e-05	0.000684	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NRAS—colon cancer	2.94e-05	0.000677	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SRC—colon cancer	2.94e-05	0.000676	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.84e-05	0.000654	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NRAS—colon cancer	2.83e-05	0.000651	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—colon cancer	2.78e-05	0.00064	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—colon cancer	2.74e-05	0.000631	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—colon cancer	2.73e-05	0.000629	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—colon cancer	2.71e-05	0.000624	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—colon cancer	2.68e-05	0.000617	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—colon cancer	2.63e-05	0.000606	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—colon cancer	2.63e-05	0.000604	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—colon cancer	2.58e-05	0.000593	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KRAS—colon cancer	2.53e-05	0.000583	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—EP300—colon cancer	2.53e-05	0.000582	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.47e-05	0.000569	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.44e-05	0.000562	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KRAS—colon cancer	2.43e-05	0.00056	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCB1—colon cancer	2.42e-05	0.000557	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TYMS—colon cancer	2.38e-05	0.000547	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—colon cancer	2.36e-05	0.000543	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—colon cancer	2.33e-05	0.000535	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—colon cancer	2.3e-05	0.000529	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CTNNB1—colon cancer	2.28e-05	0.000524	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—colon cancer	2.27e-05	0.000523	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—colon cancer	2.25e-05	0.000518	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—colon cancer	2.24e-05	0.000514	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1A—colon cancer	2.22e-05	0.000512	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HRAS—colon cancer	2.15e-05	0.000495	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EP300—colon cancer	2.12e-05	0.000487	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HRAS—colon cancer	2.07e-05	0.000476	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SRC—colon cancer	2.06e-05	0.000474	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—colon cancer	2e-05	0.000461	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.99e-05	0.000457	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NRAS—colon cancer	1.98e-05	0.000456	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.96e-05	0.000452	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCB1—colon cancer	1.92e-05	0.000442	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.92e-05	0.000442	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—colon cancer	1.9e-05	0.000437	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMS—colon cancer	1.89e-05	0.000434	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—colon cancer	1.87e-05	0.000431	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—colon cancer	1.84e-05	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—colon cancer	1.84e-05	0.000423	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.83e-05	0.000421	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—colon cancer	1.83e-05	0.00042	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—colon cancer	1.8e-05	0.000415	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGFR3—colon cancer	1.8e-05	0.000414	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KRAS—colon cancer	1.7e-05	0.000392	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—colon cancer	1.68e-05	0.000387	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APC—colon cancer	1.65e-05	0.000381	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.6e-05	0.000368	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—colon cancer	1.57e-05	0.00036	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.56e-05	0.00036	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCB1—colon cancer	1.56e-05	0.00036	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—BRAF—colon cancer	1.55e-05	0.000358	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMS—colon cancer	1.54e-05	0.000353	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—colon cancer	1.53e-05	0.000352	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—colon cancer	1.51e-05	0.000348	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.45e-05	0.000334	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HRAS—colon cancer	1.45e-05	0.000333	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—colon cancer	1.34e-05	0.000308	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—colon cancer	1.32e-05	0.000305	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.3e-05	0.000299	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—colon cancer	1.28e-05	0.000294	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCB1—colon cancer	1.27e-05	0.000293	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMS—colon cancer	1.25e-05	0.000288	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.18e-05	0.000272	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CTNNB1—colon cancer	1.12e-05	0.000259	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—EP300—colon cancer	1.1e-05	0.000253	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1A—colon cancer	1.1e-05	0.000253	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—colon cancer	1.09e-05	0.00025	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EP300—colon cancer	1.04e-05	0.00024	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SRC—colon cancer	1.02e-05	0.000234	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NRAS—colon cancer	9.77e-06	0.000225	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.62e-06	0.000221	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—colon cancer	9.1e-06	0.000209	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—colon cancer	9.08e-06	0.000209	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—colon cancer	8.9e-06	0.000205	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—colon cancer	8.85e-06	0.000204	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—EP300—colon cancer	8.75e-06	0.000201	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—colon cancer	8.56e-06	0.000197	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KRAS—colon cancer	8.41e-06	0.000193	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—colon cancer	8.15e-06	0.000188	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—colon cancer	7.73e-06	0.000178	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HRAS—colon cancer	7.15e-06	0.000164	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—EP300—colon cancer	7.12e-06	0.000164	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—colon cancer	6.96e-06	0.00016	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—colon cancer	6.66e-06	0.000153	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—colon cancer	6.47e-06	0.000149	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—colon cancer	6.31e-06	0.000145	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—EP300—colon cancer	5.79e-06	0.000133	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—colon cancer	5.29e-06	0.000122	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—colon cancer	5.26e-06	0.000121	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—colon cancer	4.3e-06	9.89e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—colon cancer	4.28e-06	9.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—colon cancer	3.5e-06	8.05e-05	CbGpPWpGaD
